Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors

Journal of Surgical Oncology

Volumn 98, Issue 3, 2008, Pages 145-146

  Nilsson, B ^a,b   Andersson, A ^a,b   Ahlman, H ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; SOMATOSTATIN RECEPTOR 1; STEM CELL FACTOR; SUNITINIB;

ADJUVANT THERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; DIARRHEA; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; EDITORIAL; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; MUTATIONAL ANALYSIS; NAUSEA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTROINTESTINAL STROMAL TUMORS; HUMANS; NEOPLASM STAGING; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 50949116904     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21043     Document Type: Editorial

References (5)

1. Bümming P, Ahlman H, Andersson J, et al.: Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours. Br J Surgery 2006;93:836-843.
2. Zhan WH: Efficacy and safety of adjuvant post-surgical therapy with imatinib in patients with high risk of relapsing GIST. Journal of Clinical Oncology 2007 ASCO Annual Meeting Proceedings; 25:556s. Abstract 10045.
3. Nilsson B, Sjölund K, Kindblom LG, et al.: Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br J Cancer 2007;96:1656-1658.
4. Simonsson T, Sjölund K, Bümming P, et al.: Reducing uncertainty in health-care resource allocation. Br J Cancer 2007;96:1834-1838.
5. Bumming P, Nilsson O, Ahlman H, et al.: Gastrointestinal stromal tumors regularly express synaptic proteins: Evidence of a neuroendocrine phenotype. Endocr Relat Cancer 2007;14:853-863.